Contamination by opportunistic screening in the European Randomized Study of Prostate Cancer Screening-Reference-Cited by-同舟云学术

Contamination by opportunistic screening in the European Randomized Study of Prostate Cancer Screening

Published:2003-12 Issue:s2 Volume:92 Page:97-100
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Ciatto S.,Zappa M.,Villers A.,Paez A.,Otto S.J.,Auvinen A.

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2003.04407.x/fullpdf

Reference27 articles.

1. 1 A Auvinen, F Calais Da Silva, LJ Denis, J Hugosson, and F Schroeder . The European Randomised Study for Prostate Cancer (ERSPC). International Cooperation and Preliminary Data . New York: Parthenon, 1996 : 167 72

2. Rationale for randomised trials of prostate cancer screening

3. Large-scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial

4. Latent Prostatic Cancer in a Consecutive Autopsy Series

5. Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future;Nature Reviews Urology;2022-08-16

2. Estimating the rate of overdiagnosis with prostate cancer screening: evidence from the Finnish component of the European Randomized Study of Screening for Prostate Cancer;Cancer Causes & Control;2021-07-27

3. Contamination in control group led to no effect of PSA-based screening on prostate cancer mortality at 9 years follow-up: Results of the French section of European Randomized Study of Screening for Prostate Cancer (ERSPC);Progrès en Urologie;2020-04

4. The Impact of Design and Performance in Prostate-Specific Antigen Screening: Differences Between ERSPC Centers;European Urology;2019-09

5. Prostate-Specific Antigen–Based Screening for Prostate Cancer;JAMA;2018-05-08